抗脂综合征中的血小板缺血:在一项大型队列研究中预测因素,预后影响和血小板风险
David Galarza1, Massimo Radin2, Irene Cecchi2
1Department of Rheumatology, Hospital del Mar-IMIM, Passeig Marítim de la Barceloneta, 25, 29, 08003, Barcelona, Spain.
Thrombosis research
|November 26, 2025
概括
抗脂综合征 (APS) 患者的血小板缺血与血栓形成风险增加和系统性问题有关. 管理需要平衡凝块预防与出血问题,特别是在严重的情况下.
科学领域:
- 自免疫性疾病 自免疫性疾病
- 血液学 血液学 血液学
- 类风湿病学 类风湿病学
背景情况:
- 抗脂综合征 (APS) 是一种与血栓形成和妊娠并发症相关的自身免疫性疾病.
- 血栓缩是一种常见的APS表现,对出血和凝血都有风险.
- 了解APS中的血小板缺血对于管理患者的治疗结果至关重要.
研究的目的:
- 调查抗脂抗体 (aPL) 阳性患者中血小板缺血的发生率,特征和预测因素.
- 分析APS中血小板缺血和其他临床表现之间的关联.
- 在aPL阳性个体中确定影响血小板缩的因素.
主要方法:
- 一个多中心的回顾性队列研究,涉及211名aPL阳性患者.
- 数据收集包括人口统计,实验室和临床特征在10年的时间.
- 血小板缺血的定义是排除其他原因,并进行了全面的临床和实验室评估.
主要成果:
- 血小板缺血发生在20%的aPL阳性患者中,严重程度各不相同.
- 患有血栓塞缩症的患者表现出更高的血栓事件率,包括静脉复发,深静脉血栓,肺栓塞和灾难性APS (CAPS).
- 在患有血小板狭窄症的患者中,观察到抗β2糖蛋白I抗体IgG和白血病的频率增加.
结论:
- 在APS患者中,尤其是严重病例中的血小板减少与血小板风险增加和全身性疾病活性相关.
- 这些发现强调了需要量身定制的策略来管理APS患者的血栓形成和出血风险.
- 针对性管理计划对于涉及血小板缺血的复杂APS病例至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis III: Interprofessional Care
268
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
268
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
277
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
277
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
Venous Thrombosis I: Introduction
321
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
321
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K


